Search
Now showing items 1-1 of 1
Rivaroxaban Pharmacokinetics in Obese Subjects: A Systematic Review
(
Springer Nature
, 2022 , Article)
Venous thromboembolism (VTE) is a leading cause of morbidity and mortality globally. The direct oral anticoagulants, including rivaroxaban, are relatively novel therapeutic options in the treatment and prevention of VTE. ...